ESCRS - FP17.08 - Visual Performance And Quality Of Visión Outcomes Obtained With Spiral Refractive Full Range Of Field Intraocular Lens: One-Year Follow-Up

Visual Performance And Quality Of Visión Outcomes Obtained With Spiral Refractive Full Range Of Field Intraocular Lens: One-Year Follow-Up

Published 2026 - 44th Congress of the ESCRS

Reference: FP17.08 | Type: Free paper | DOI: 10.82333/9tdk-jx52

Authors: A/Prof. Alfonso Arias- Puente* 1 , Dr Jose L Rincón 2 , Mrs Lucia Infestas 3 , Dr Paloma Arias-Gómez de Liaño 4 , A/Prof. David P Piñero 5

1OPHTHALMOLOGY,REY JUAN CARLOS UNIVERSITY,MADRID,Spain;INSTITUTE OF OPHTHALMOLOGY,VITHAS INTERNATIONAL UNIVERSITY HOSPITAL,MADRID,Spain;OPTHALMOLOGY,GOMEZ DE LIAÑO EYE CENTER,MADRID,Spain, 2INSTITUTE OF OPHTHALMOLOGY,VITHAS INTERNATIONAL UNIVERSITY HOSPITAL,ALICANTE,Spain, 3INSTITUTE OF OPHTHALMOLOGY,VITHAS INTERNATIONAL UNIVERSITY HOSPITAL,MADRID,Spain, 4INSTITUTE OF OPHTHALMOLOGY,VITHAS INTERNATIONAL UNIVERSITY HOSPITAL,MADRID,Spain;OPHTHALMOLOGY,GOMEZ DE LIAÑO EYE CENTER,MADRID,Spain, 5OPTICS, PHARMACOLOGY AND ANATOMY,UNIVERSITY OF ALICANTE,ALICANTE,Spain;INSTITUTE OF OPHTHALMOLOGY,VITHAS INTERNATIONAL UNIVERSITY HOSPITAL,ALICANTE,Spain

Purpose

To evaluate the functional visual outcomes and quality of vision obtained with a spiral refractive full range of field (FRoF) intraocular lens (IOL) at one year follow-up.

Setting

Department of Ophthalmology. University Vithas International University Hospital. Madrid-Alicante Spain 

Methods

This prospective, multicenter, longitudinal, observational, and non-comparative study included a total of 72 patients with mean age 65,65 ± 9,14 years old (r 49-79) All cases underwent uncomplicated cataract surgery with intraocular lens implant  of RayOne Galaxy® IOL (Rayner, West Sussex, UK) implantation. Visual acuity was assessed 12 months post-surgery, including corrected and uncorrected visual acuity  for far ((UDVA, CDVA), intermediate (UIVA, DCIVA), and near (UNAV, DCNVA)  distances, photopic and mesopic achromatic contrast sensitivity (CS) (CSV-1000 test), halos and glare (Eyeland Design Network GmbH®), improvement in quality of life, satisfaction rates, and spectacle independence.

Results

All cases achieved binocular CDVA values ​​≤ 0.0 logMAR, DCIVA ≤ 0.1 logMAR, and DCNVA ≤ 0.2 logMAR. The defocus curve showed CDVA (0.0D)  -0,05 ± 0,02 logMAR, DCIVA (-1,5D) -0,02 ± 0,01 and DCNVA (-2,5D) 0,10 ± 0,07. Regarding CS distance at 3,6,12,18 c/d in photopic CS were 6±1,51, 5,32 ± 1,16, 5,80 ± 1,37, 4,12 ± 1,08 and in mesopic CS 5,66 ± 1,57, 5,29 ± 1,29,  5,79 ± 1,74, 4,15 1,10 respectively. The average halo size was 28.5 ± 16.21, with 97.2% of cases reporting no clinically significant halos and 100% without glare.16.66% of eyes required posterior capsulotomy with mean time of 323.44 ± 95.12 days (r146–386). Spectacle independence was achieved in 93.0% for distance vision, 94.4% for intermediate vision, and 84.7% for near vision.

.

Conclusions

The evaluated FRoF IOL provides, at one year of follow-up, functional performance that allows good levels of visual acuity for far, intermediate and near vision with minimal impact on contrast sensitivity at distance, minimal dysphotopsia and acceptable spectacle independence. 

These visual outcomes  remained stable since the first month of follow-up.